Literature DB >> 28984359

Strategies to retain properties of bone marrow-derived mesenchymal stem cells ex vivo.

Yaxian Zhou1,2, Tsung-Lin Tsai1,2, Wan-Ju Li1,2.   

Abstract

Mesenchymal stem cells (MSCs) have been extensively used for cell therapies and tissue engineering. The current MSC strategy requires a large quantity of cells for such applications, which can be achieved through cell expansion in culture. In the body, stem cell fate is largely determined by their microenvironment, known as the niche. The complex and dynamic stem cell niche provides physical, mechanical, and chemical cues to collaboratively regulate cell activities. It remains a great challenge to maintain the properties of MSCs in culture. Constructing a microenvironment as an engineered stem cell niche in culture to maintain MSC phenotypes, properties, and functions is a viable strategy to address the issue. Here, we review the current understanding of MSC behavior in the bone marrow niche, describe different strategies to engineer an in vitro microenvironment for maintaining MSC properties and functions, and discuss previous findings on environmental factors critical to the modulation of MSC activities in engineered microenvironments.
© 2017 New York Academy of Sciences.

Entities:  

Keywords:  mesenchymal stem cell; microenvironment; niche; regenerative medicine; tissue engineering

Mesh:

Year:  2017        PMID: 28984359      PMCID: PMC5730506          DOI: 10.1111/nyas.13451

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  166 in total

1.  Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study.

Authors:  Marjolijn Duijvestein; Anne Christine W Vos; Helene Roelofs; Manon E Wildenberg; Barbara B Wendrich; Henricus W Verspaget; Engelina M C Kooy-Winkelaar; Frits Koning; Jaap Jan Zwaginga; Herma H Fidder; Auke P Verhaar; Willem E Fibbe; Gijs R van den Brink; Daniel W Hommes
Journal:  Gut       Date:  2010-10-04       Impact factor: 23.059

2.  Type I collagen promotes proliferation and osteogenesis of human mesenchymal stem cells via activation of ERK and Akt pathways.

Authors:  Kuo-Shu Tsai; Shou-Yen Kao; Chien-Yuan Wang; Yng-Jiin Wang; Jung-Pan Wang; Shih-Chieh Hung
Journal:  J Biomed Mater Res A       Date:  2010-09-01       Impact factor: 4.396

3.  Influence of mesenchymal stem cells with endothelial progenitor cells in co-culture on osteogenesis and angiogenesis: an in vitro study.

Authors:  Qiong Li; Zuolin Wang
Journal:  Arch Med Res       Date:  2013-10-10       Impact factor: 2.235

Review 4.  "Mesenchymal" stem cells.

Authors:  Paolo Bianco
Journal:  Annu Rev Cell Dev Biol       Date:  2014-08-18       Impact factor: 13.827

5.  Matrix elasticity, replicative senescence and DNA methylation patterns of mesenchymal stem cells.

Authors:  Anne Schellenberg; Sylvia Joussen; Kristin Moser; Nico Hampe; Nils Hersch; Hatim Hemeda; Jan Schnitker; Bernd Denecke; Qiong Lin; Norbert Pallua; Martin Zenke; Rudolf Merkel; Bernd Hoffmann; Wolfgang Wagner
Journal:  Biomaterials       Date:  2014-05-10       Impact factor: 12.479

6.  Low ATP level is sufficient to maintain the uncommitted state of multipotent mesenchymal stem cells.

Authors:  L B Buravkova; Y V Rylova; E R Andreeva; A V Kulikov; M V Pogodina; B Zhivotovsky; V Gogvadze
Journal:  Biochim Biophys Acta       Date:  2013-06-04

7.  Intramyocardial injections of human mesenchymal stem cells following acute myocardial infarction modulate scar formation and improve left ventricular function.

Authors:  Jan Otto Beitnes; Erik Oie; Aboulghassem Shahdadfar; Tommy Karlsen; Regine M B Müller; Svend Aakhus; Finn P Reinholt; Jan E Brinchmann
Journal:  Cell Transplant       Date:  2012-03-08       Impact factor: 4.064

8.  Hypoxia inhibits senescence and maintains mesenchymal stem cell properties through down-regulation of E2A-p21 by HIF-TWIST.

Authors:  Chih-Chien Tsai; Yann-Jang Chen; Tu-Lai Yew; Ling-Lan Chen; Jir-You Wang; Chao-Hua Chiu; Shih-Chieh Hung
Journal:  Blood       Date:  2010-10-15       Impact factor: 22.113

9.  Focal adhesions are sites of integrin extension.

Authors:  Janet A Askari; Christopher J Tynan; Stephen E D Webb; Marisa L Martin-Fernandez; Christoph Ballestrem; Martin J Humphries
Journal:  J Cell Biol       Date:  2010-03-15       Impact factor: 10.539

10.  Immunochemical localization of extracellular materials in bone marrow of rats.

Authors:  R Hamilton; F R Campbell
Journal:  Anat Rec       Date:  1991-10
View more
  15 in total

1.  The Isolation and Manufacture of GMP-Grade Bone Marrow Stromal Cells from Bone Specimens.

Authors:  Rhayra B Dias; Danielle C Bonfim
Journal:  Methods Mol Biol       Date:  2021

2.  Immortalizing Mesenchymal Stromal Cells from Aged Donors While Keeping Their Essential Features.

Authors:  María Piñeiro-Ramil; Rocío Castro-Viñuelas; Clara Sanjurjo-Rodríguez; Silvia Rodríguez-Fernández; Tamara Hermida-Gómez; Francisco J Blanco-García; Isaac Fuentes-Boquete; Silvia Díaz-Prado
Journal:  Stem Cells Int       Date:  2020-06-16       Impact factor: 5.443

Review 3.  3D Bone Biomimetic Scaffolds for Basic and Translational Studies with Mesenchymal Stem Cells.

Authors:  Cristina Sobacchi; Marco Erreni; Dario Strina; Eleonora Palagano; Anna Villa; Ciro Menale
Journal:  Int J Mol Sci       Date:  2018-10-13       Impact factor: 5.923

4.  A pH probe inhibits senescence in mesenchymal stem cells.

Authors:  Lihong Wang; Xianjing Han; Guojing Qu; Le Su; Baoxiang Zhao; Junying Miao
Journal:  Stem Cell Res Ther       Date:  2018-12-07       Impact factor: 6.832

Review 5.  Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies.

Authors:  Nádia de Cássia Noronha; Amanda Mizukami; Carolina Caliári-Oliveira; Juçara Gastaldi Cominal; José Lucas M Rocha; Dimas Tadeu Covas; Kamilla Swiech; Kelen C R Malmegrim
Journal:  Stem Cell Res Ther       Date:  2019-05-02       Impact factor: 6.832

6.  Characterisation of multipotent stem cells from human peripheral blood using an improved protocol.

Authors:  Weiping Lin; Liangliang Xu; Sien Lin; Liu Shi; Bin Wang; Qi Pan; Wayne Y W Lee; Gang Li
Journal:  J Orthop Translat       Date:  2019-03-07       Impact factor: 5.191

7.  TNFR2 Is a Crucial Hub Controlling Mesenchymal Stem Cell Biological and Functional Properties.

Authors:  Ghada Beldi; Sheyda Bahiraii; Chloé Lezin; Mahsa Nouri Barkestani; Mohamed Essameldin Abdelgawad; Georges Uzan; Sina Naserian
Journal:  Front Cell Dev Biol       Date:  2020-12-04

Review 8.  Bone Marrow-Derived Mesenchymal Stromal Cells: A Novel Target to Optimize Hematopoietic Stem Cell Transplantation Protocols in Hematological Malignancies and Rare Genetic Disorders.

Authors:  Stefania Crippa; Ludovica Santi; Roberto Bosotti; Giulia Porro; Maria Ester Bernardo
Journal:  J Clin Med       Date:  2019-12-18       Impact factor: 4.241

9.  The Manufacture of GMP-Grade Bone Marrow Stromal Cells with Validated In Vivo Bone-Forming Potential in an Orthopedic Clinical Center in Brazil.

Authors:  Rhayra B Dias; João A M Guimarães; Marco B Cury; Leonardo R Rocha; Elaine S da Costa; Liebert P Nogueira; Camila Hochman-Mendez; Anneliese Fortuna-Costa; Anna Karoline F Silva; Karin S Cunha; Sergio A L de Souza; Maria Eugênia L Duarte; Rafaela C Sartore; Danielle C Bonfim
Journal:  Stem Cells Int       Date:  2019-11-07       Impact factor: 5.443

10.  Silica-Coated Magnetic Nanoparticles Decrease Human Bone Marrow-Derived Mesenchymal Stem Cell Migratory Activity by Reducing Membrane Fluidity and Impairing Focal Adhesion.

Authors:  Tae Hwan Shin; Da Yeon Lee; Abdurazak Aman Ketebo; Seungah Lee; Balachandran Manavalan; Shaherin Basith; Chanyoung Ahn; Seong Ho Kang; Sungsu Park; Gwang Lee
Journal:  Nanomaterials (Basel)       Date:  2019-10-17       Impact factor: 5.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.